Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,370,197
+$2,831,464 QoQ
Shares Held
504,718
+86.5% QoQ
Ownership
0.808%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. DSGN ranks #177 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in DSGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,370,197 | 504,718 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,538,733 | 270,654 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,968,680 | 261,445 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $806,976 | 239,459 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,026,821 | 266,016 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,833,285 | 297,129 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,482,361 | 275,532 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,022,411 | 603,705 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,040,211 | 506,256 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,712,865 | 1,023,723 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,049,014 | 444,498 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,818,720 | 447,416 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,734,599 | 300,624 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,816,071 | 274,471 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $16,613,744 | 993,645 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,277,318 | 91,237 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,891,681 | 117,132 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,452,411 | 67,838 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $809,918 | 55,134 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $419,241 | 21,078 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,495,155 | 83,450 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||